Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Human Tendon Tissue Collection

18 de maio de 2026 atualizado por: Queen Mary University of London

Human Tendon Tissue Collection for In Vitro Models and Tissue Analysis

The goal of this study is to improve understanding of tendon health and disease by using surplus tendon tissue that is routinely removed during planned orthopaedic surgeries in adults. The main questions it aims to answer are:

- What can tendon tissue and tendon cells tell us about how healthy and diseased tendons function?

Participants will not undergo any extra procedures. Instead, researchers will use only tissue that is already being removed as part of normal surgical care and would otherwise be discarded.

Participants will:

  • Be asked for permission (consent) before their surgery to donate any surplus tendon tissue.
  • Have a small piece of tendon tissue (normally waste material) collected during their planned operation.
  • Allow the research team to access some non-identifiable medical information (such as age, reason for surgery, and relevant medical history) to help interpret research findings.

What the researchers will do with the donated tissue:

  • Isolate different types of human tendon cells.
  • Build advanced laboratory cellular models to study how tendon diseases develop.
  • Analyse whole tendon tissue sections to understand cell types, tissue organisation, and disease-related changes.

This study does not involve testing treatments, and it does not change any aspect of a participant's clinical care. Although there is no direct benefit to participants, the donated tissue may help researchers develop better ways to study tendon injuries and improve future treatment options for tendon disease.

Visão geral do estudo

Descrição detalhada

This study aims to improve our understanding of how human tendons work, why they become injured, and how tendon diseases develop. Tendon problems-such as tendinopathy-are common and can cause long-lasting pain and loss of mobility. Scientists currently lack good laboratory models that accurately represent real human tendon tissue, which makes it harder to study these conditions or test new treatments.

During many types of planned orthopaedic surgery, small pieces of tendon tissue are routinely removed because they are no longer needed for the patient's care. Normally, this tissue would simply be thrown away. In this study, patients who are already having surgery are invited to donate this surplus tissue for research.

How the study works:

If a patient agrees to take part, the healthcare team will collect the leftover tendon tissue during their planned operation. There are no extra procedures, no changes to the surgery, and nothing additional that the patient needs to do.

After collection, the tissue is taken to research laboratories at Queen Mary University of London. There, scientists use it in two main ways:

  1. Studying the tendon tissue itself:

    Researchers examine the structure and cells within the tendon to study how tendon cells are organised.

  2. Growing tendon cells in the lab:

The donated tissue allows researchers to isolate living tendon cells. These cells can then be used to build more advanced laboratory models-such as "tendon-on-a-chip" systems-that mimic how tendons experience movement, load, and interaction with other cell types. These models will help scientists study disease processes and could support the development of new treatments in the future.

To support this work, the research team also receives a small amount of non-identifiable medical information about each donor-such as age, general health information, and the reason for surgery. This helps researchers understand how different factors may influence tendon biology. All personal details (like names or NHS numbers) remain within the hospital and are never shared with the research team.

Why this research matters:

Human tendon tissue is rarely available for research, yet it is essential for creating accurate models and understanding real-world disease. By using tissue that would otherwise be discarded, this study will:

  • Provide new insights into how tendons function and how tendon diseases develop.
  • Help researchers design more realistic laboratory systems to study tendon conditions.
  • Support future work aiming to improve diagnosis, prevention, and treatment of tendon disorders.

Although participants will not directly benefit, their donated tissue may contribute to scientific progress that improves care for people with tendon injuries in the future.

Tipo de estudo

Observacional

Inscrição (Estimado)

400

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Adulto
  • Adulto mais velho

Aceita Voluntários Saudáveis

Não

Método de amostragem

Amostra Não Probabilística

População do estudo

Patients scheduled to undergo orthopaedic lower limb surgery at the Royal London, Whipps Cross University Hospital and the Barts Health Orthopaedic Centre in Newham.

Descrição

Inclusion Criteria:

  • 18 years or older
  • Scheduled to undergo orthopaedic lower limb surgery that involve tendon tissue waste
  • Have provided informed consent to take part in the study

Exclusion Criteria:

  • Under the age of 18
  • Unable or unwilling to give informed consent (including those with limited English proficiency)
  • Cases where tendon tissue is required for clinical care and therefore not surplus.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Obtain sufficient tendon tissue samples.
Prazo: Perioperative to immediate post-collection laboratory processing (within 24 hours).
The main outcome of this project is to obtain sufficient tendon tissue to isolate different human tendon cells and perform tissue analysis.
Perioperative to immediate post-collection laboratory processing (within 24 hours).

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Investigadores

  • Investigador principal: Hazel Screen, Professor, PhD, Queen Mary University of London

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

1 de junho de 2026

Conclusão Primária (Estimado)

1 de junho de 2031

Conclusão do estudo (Estimado)

1 de junho de 2031

Datas de inscrição no estudo

Enviado pela primeira vez

1 de abril de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

18 de maio de 2026

Primeira postagem (Real)

26 de maio de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

26 de maio de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

18 de maio de 2026

Última verificação

1 de maio de 2026

Mais Informações

Termos relacionados a este estudo

Palavras-chave

Outros números de identificação do estudo

  • 368295

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Descrição do plano IPD

No individual participant data will be shared. All data used in the study are pseudonymised before transfer to the research team, and identifiable information remains within the NHS clinical environment. No IPD dataset suitable for external sharing will be generated.

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever